GlassScriptPhysician profile
Symeon Missios
NPI 1144336538
$3,619.36
in general payments reported to CMS, 2019-2025
15 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $2,054 · 2021: $183 · 2022: $186 · 2023: $264 · 2024: $524 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $2,137.40 | 2019-2020 | |
| Stryker Corporation | $412.69 | 2019-2025 | Core, Nico Myriad Spectra, Ivas |
| Djo, LLC | $160.35 | 2024 | Cmf |
| Novocure INC. | $147.24 | 2020-2023 | Optune |
| Abbott Laboratories | $131.32 | 2021-2025 | Proclaim |
| Nevro Corp. | $116.64 | 2020-2022 | |
| Mimedx Group, INC. | $114.97 | 2024 | |
| Nuvasive, INC. | $81.89 | 2022 | |
| Medtronic, INC. | $80.75 | 2024-2025 | Inceptiv, Vanta Adaptivestim, Intellis Adaptivestim |
| Zimvie INC. | $70.72 | 2024 | |
| Orthofix Medical, INC. | $62.08 | 2024 | Spinal-Stim |
| Curonix LLC | $49.52 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $23.04 | 2023 | Ztlido |
| Janssen Pharmaceuticals, INC | $18.52 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Symeon Missios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.